This Page Score: 0/40
Assertion (A):
Transgenic animals are used for vaccine safety testing.
Reason (R):
Transgenic mice are currently being developed to test the safety of the polio vaccine and potentially replace the use of monkeys.
[Biotechnology-and-its-Applications] [class-xii ]
Assertion (A):
Molecular diagnosis using PCR is crucial for detecting diseases like HIV and cancer.
Reason (R):
PCR is highly sensitive, allowing amplification of nucleic acid when the pathogen concentration is low, before symptoms are visible.
[Biotechnology-and-its-Applications] [class-xii ]
Assertion (A):
Transgenic animals are used for chemical safety testing.
Reason (R):
These animals are engineered to be more sensitive to toxic substances, which accelerates the testing process and reduces the time required to obtain results.
[Biotechnology-and-its-Applications] [class-xii ]
Assertion (A):
ELISA is a molecular diagnostic technique that detects infection based on antigen-antibody interaction.
Reason (R):
Infection can be detected by identifying the presence of the pathogen (antigen) or the specific antibodies synthesized against it by the host.
[Biotechnology-and-its-Applications] [class-xii ]
Assertion (A):
Biopiracy predominantly harms the financial interests of industrialized nations.
Reason (R):
Industrialized nations are generally poor in biodiversity and traditional knowledge, making them targets of unauthorized exploitation by multinational companies.
[Biotechnology-and-its-Applications] [class-xii ]
Assertion (A):
ADA deficiency can be permanently cured by enzyme replacement therapy.
Reason (R):
The only permanent cure for ADA deficiency involves introducing the functional ADA gene into cells at an early embryonic stage.
[Biotechnology-and-its-Applications] [class-xii ]
Assertion (A):
Somaclones are plants produced asexually through micro-propagation.
Reason (R):
Somaclones are genetically identical to the original parent plant because they are generated from an explant, relying on the process of totipotency.
[Biotechnology-and-its-Applications] [class-xii ]
Assertion (A):
The Bt toxin protein exists as an inactive protoxin within the bacterium *Bacillus thuringiensis*.
Reason (R):
The protein crystals remain inactive in the bacterium because the toxin only becomes activated in the presence of the high pH (alkaline conditions) found in the insect gut.
[Biotechnology-and-its-Applications] [class-xii ]
Assertion (A):
Recombinant therapeutics are safer and more effective than similar products isolated from non-human sources.
Reason (R):
Recombinant products are structurally identical to natural human proteins and thus do not trigger unwanted immunological responses or risk infection transmission.
[Biotechnology-and-its-Applications] [class-xii ]
Assertion (A):
The production of human insulin via rDNA technology requires the separate production of the A and B polypeptide chains.
Reason (R):
The bacterial host (*E. coli*) does not possess the enzymatic machinery required to remove the C peptide from pro-insulin, necessitating external synthesis of the disulphide bonds.
[Biotechnology-and-its-Applications] [class-xii ]
This Page Score: 0/40